Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
CANCER:
Kaposi Sarcoma
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Related cancers:
‹
Sarcoma (668
)
Soft Tissue Sarcoma (443
)
Spindle Cell Sarcoma (100
)
Leiomyosarcoma (54
)
Osteosarcoma (54
)
Ewing Sarcoma (45
)
Fibrosarcoma (34
)
Rhabdomyosarcoma (34
)
Liposarcoma (25
)
Uterine Corpus Leiomyosarcoma (23
)
Neurofibrosarcoma (13
)
Sarcoma (668
)
Soft Tissue Sarcoma (443
)
Spindle Cell Sarcoma (100
)
Leiomyosarcoma (54
)
Osteosarcoma (54
)
Ewing Sarcoma (45
)
Fibrosarcoma (34
)
Rhabdomyosarcoma (34
)
Liposarcoma (25
)
Uterine Corpus Leiomyosarcoma (23
)
Neurofibrosarcoma (13
)
›
Associations
(13)
News
Trials
VERI cancer hierarchy
Reset Filters
No biomarker
Kaposi Sarcoma
No biomarker
Kaposi Sarcoma
pegylated liposomal doxorubicin
Sensitive: A1 - Approval
pegylated liposomal doxorubicin
Sensitive
:
A1
pegylated liposomal doxorubicin
Sensitive: A1 - Approval
pegylated liposomal doxorubicin
Sensitive
:
A1
No biomarker
Kaposi Sarcoma
No biomarker
Kaposi Sarcoma
pomalidomide
Sensitive: A1 - Approval
pomalidomide
Sensitive
:
A1
pomalidomide
Sensitive: A1 - Approval
pomalidomide
Sensitive
:
A1
No biomarker
Kaposi Sarcoma
No biomarker
Kaposi Sarcoma
vinorelbine tartrate
Sensitive: A2 - Guideline
vinorelbine tartrate
Sensitive
:
A2
vinorelbine tartrate
Sensitive: A2 - Guideline
vinorelbine tartrate
Sensitive
:
A2
No biomarker
Kaposi Sarcoma
No biomarker
Kaposi Sarcoma
gemcitabine
Sensitive: A2 - Guideline
gemcitabine
Sensitive
:
A2
gemcitabine
Sensitive: A2 - Guideline
gemcitabine
Sensitive
:
A2
No biomarker
Kaposi Sarcoma
No biomarker
Kaposi Sarcoma
albumin-bound paclitaxel
Sensitive: A2 - Guideline
albumin-bound paclitaxel
Sensitive
:
A2
albumin-bound paclitaxel
Sensitive: A2 - Guideline
albumin-bound paclitaxel
Sensitive
:
A2
No biomarker
Kaposi Sarcoma
No biomarker
Kaposi Sarcoma
etoposide oral
Sensitive: A2 - Guideline
etoposide oral
Sensitive
:
A2
etoposide oral
Sensitive: A2 - Guideline
etoposide oral
Sensitive
:
A2
No biomarker
Kaposi Sarcoma
No biomarker
Kaposi Sarcoma
lenalidomide
Sensitive: A2 - Guideline
lenalidomide
Sensitive
:
A2
lenalidomide
Sensitive: A2 - Guideline
lenalidomide
Sensitive
:
A2
No biomarker
Kaposi Sarcoma
No biomarker
Kaposi Sarcoma
YD312
Sensitive: A2 - Guideline
YD312
Sensitive
:
A2
YD312
Sensitive: A2 - Guideline
YD312
Sensitive
:
A2
No biomarker
Kaposi Sarcoma
No biomarker
Kaposi Sarcoma
thalidomide
Sensitive: A2 - Guideline
thalidomide
Sensitive
:
A2
thalidomide
Sensitive: A2 - Guideline
thalidomide
Sensitive
:
A2
No biomarker
Kaposi Sarcoma
No biomarker
Kaposi Sarcoma
bortezomib
Sensitive: A2 - Guideline
bortezomib
Sensitive
:
A2
bortezomib
Sensitive: A2 - Guideline
bortezomib
Sensitive
:
A2
No biomarker
Kaposi Sarcoma
No biomarker
Kaposi Sarcoma
sirolimus
Sensitive: A2 - Guideline
sirolimus
Sensitive
:
A2
sirolimus
Sensitive: A2 - Guideline
sirolimus
Sensitive
:
A2
No biomarker
Kaposi Sarcoma
No biomarker
Kaposi Sarcoma
paclitaxel
Sensitive: A2 - Guideline
paclitaxel
Sensitive
:
A2
paclitaxel
Sensitive: A2 - Guideline
paclitaxel
Sensitive
:
A2
PD-L1 expression
Kaposi Sarcoma
PD-L1 expression
Kaposi Sarcoma
pembrolizumab
Sensitive: C1 - Off-label
pembrolizumab
Sensitive
:
C1
pembrolizumab
Sensitive: C1 - Off-label
pembrolizumab
Sensitive
:
C1
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login